日本脐部子宫内膜异位症全国调查
本研究为日本全国性回顾性调查,纳入2006至2016年病理确诊的96例良性脐部子宫内膜异位症患者及2例恶变病例,评估其临床表现、诊断方法、治疗及术后复发情况。结果显示术后累积复发率6个月为1.34%、12个月为6.35%、60个月为6.35%,宽切除术(含腹膜)后37例无复发;地诺孕素、GnRH激动剂和口服避孕药的有效率分别为91.7%、81.8%和57.1%。结论认为手术是首选治疗,激素治疗为可选方案。
要点
- 脐部子宫内膜异位症常见表现为脐部肿胀(86.5%)、疼痛(81.3%)和出血(44.8%)。
- 术后累积复发率6个月1.34%、12个月6.35%、60个月6.35%。
- 宽切除术(含腹膜)后37例无复发。
核心结论
- 手术后复发率低,激素治疗为可选方案,但当前结果提示手术是脐部子宫内膜异位症的首选治疗。
研究设计与样本
- 回顾性全国调查,纳入2006年至2016年日本教学医院妇产科和整形外科的脐部子宫内膜异位症或恶变病例。
- 共纳入96例病理确诊的良性脐部子宫内膜异位症患者,另发现2例恶变病例。
主要发现
- 脐部肿胀占86.5%、疼痛占81.3%、出血占44.8%。
- 敏感性:体格检查87.1%、经腹超声76.5%、计算机断层扫描75.6%、磁共振成像81.8%。
- 术后累积复发率:6个月1.34%、12个月6.35%、60个月6.35%。
- 宽切除术(含腹膜)后37例中无复发(0/37)。
- 地诺孕素、促性腺激素释放激素激动剂和口服避孕药的有效率分别为91.7%、81.8%和57.1%。
关键数值与推荐
- 宽切除术(含腹膜)后37例中无复发(0/37)。
- 地诺孕素有效率为91.7%,促性腺激素释放激素激动剂为81.8%,口服避孕药为57.1%。
临床怎么用
- 当前结果提示手术是脐部子宫内膜异位症的首选治疗,激素治疗为可选方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To identify the clinical presentation, diagnostic evaluation, operative or medical management, and postoperative recurrence of umbilical endometriosis. DESIGN: A retrospective national survey. SETTING: Obstetrics and Gynecology and Plastic Surgery Departments at a teaching hospital in Japan. PATIENTS: Patients with umbilical endometriosis or malignant transformation. INTERVENTIONS: A national survey was conducted to identify and evaluate cases of umbilical endometriosis or malignant transformation documented between 2006 and 2016. MEASUREMENTS AND MAIN RESULTS: The following were evaluated for each patient: age at diagnosis, body mass index, medical history, presence of extragenital endometriosis, surgical history, symptoms, imaging modalities, surgical therapy, hormonal therapy, follow-up period, postoperative recurrence, and time to recurrence. Ninety-six patients were identified with pathologically diagnosed benign umbilical endometriosis. The patients frequently had swelling (86.5%), pain (81.3%), or bleeding (44.8%) in the umbilicus. Sensitivity was 87.1% for physical examination, 76.5% for transabdominal ultrasonography, 75.6% for computed tomography, and 81.8% for magnetic resonance imaging. The cumulative recurrence rate was 1.34% at 6 months, 6.35% at 12 months, and 6.35% at 60 months after surgery. Importantly, there was no recurrence after wide resection including of the peritoneum (0 of 37 cases). The efficacy of dienogest (an oral progestin), gonadotropin-releasing hormone agonists, and oral contraceptives was 91.7%, 81.8%, and 57.1%, respectively. Finally, 2 cases of malignant transformation were identified. CONCLUSION: There was a low recurrence rate following surgery, and hormonal treatment is an option, although the current findings suggest surgical therapy as the first choice of treatment for umbilical endometriosis.
引用
- Hirata T, Koga K, Kitade M, et al. A National Survey of Umbilical Endometriosis in Japan. J Minim Invasive Gynecol. 2019. PMID: 30965115. doi:10.1016/j.jmig.2019.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。